Daniel Lin

Senior Director, Metabolic Diseases


PhD. in Biology, MIT; BA in Molecular and Cell Biology, UC Berkeley.

Previous Experience:

Prior to insitro, I was at Amgen and 23andMe, running drug discovery projects through the pipeline.

Responsibilities at insitro:

I am responsible for drug discovery, target validation, biology, strategy, collaboration, mentoring and team building.